{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:49Z","timestamp":1786982209256,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160794"],"award-info":[{"award-number":["82160794"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s12033-024-01106-9","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T07:01:52Z","timestamp":1714633312000},"page":"1077-1094","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanism of Si Ni San Combined with Astragalus in Treating Hepatic Fibrosis: A Network Pharmacology and Molecular Docking Study"],"prefix":"10.1007","volume":"67","author":[{"given":"Jiu","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuwang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2724-7156","authenticated-orcid":false,"given":"Li-dao","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"1106_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fphys.2015.00209","volume":"6","author":"J Lambrecht","year":"2015","unstructured":"Lambrecht, J., Mannaerts, I., & van Grunsven, L. A. (2015). The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis. Frontiers in Physiology, 6, 209. https:\/\/doi.org\/10.3389\/fphys.2015.00209","journal-title":"Frontiers in Physiology"},{"issue":"10","key":"1106_CR2","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00204-015-1525-6","volume":"89","author":"RJ Chen","year":"2015","unstructured":"Chen, R. J., Wu, H. H., & Wang, Y. J. (2015). Strategies to prevent and reverse liver fibrosis in humans and laboratory animals. Archives of Toxicology, 89(10), 1727\u20131750. https:\/\/doi.org\/10.1007\/s00204-015-1525-6","journal-title":"Archives of Toxicology"},{"issue":"1","key":"1106_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3892\/ijmm.2019.4395","volume":"45","author":"BM Wu","year":"2020","unstructured":"Wu, B. M., Liu, J. D., Li, Y. H., & Li, J. (2020). Margatoxin mitigates CCl4-induced hepatic fibrosis in mice via macrophage polarization, cytokine secretion and STAT signaling. International Journal of Molecular Medicine, 45(1), 103\u2013114. https:\/\/doi.org\/10.3892\/ijmm.2019.4395","journal-title":"International Journal of Molecular Medicine"},{"issue":"2","key":"1106_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41575-020-00406-0","volume":"18","author":"MF Abdelmalek","year":"2021","unstructured":"Abdelmalek, M. F. (2021). Nonalcoholic fatty liver disease: Another leap forward. Nature Reviews. Gastroenterology & Hepatology, 18(2), 85\u201386. https:\/\/doi.org\/10.1038\/s41575-020-00406-0","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"1106_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cbi.2016.11.022","volume":"261","author":"AA Ganai","year":"2017","unstructured":"Ganai, A. A., & Husain, M. (2017). Genistein attenuates D-GalN induced liver fibrosis\/chronic liver damage in rats by blocking the TGF-\u03b2\/Smad signaling pathways. Chemico-Biological Interactions, 261, 80\u201385. https:\/\/doi.org\/10.1016\/j.cbi.2016.11.022","journal-title":"Chemico-Biological Interactions"},{"key":"1106_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113226","volume":"264","author":"H Ge","year":"2021","unstructured":"Ge, H., Wang, A., Su, Y., Yu, C., Gao, L., & Li, Y. (2021). Ameliorative effects of Qingganjiuwei powder, a traditional Mongolian medicine, against CCl(4)-induced liver fibrosis in rats. Journal of Ethnopharmacology, 264, 113226. https:\/\/doi.org\/10.1016\/j.jep.2020.113226","journal-title":"Journal of Ethnopharmacology"},{"key":"1106_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-981-13-9367-9_10","volume":"1172","author":"MC Mulero","year":"2019","unstructured":"Mulero, M. C., Huxford, T., & Ghosh, G. (2019). NF-\u03baB, I\u03baB, and IKK: Integral components of immune system signaling. Advances in Experimental Medicine and Biology, 1172, 207\u2013226. https:\/\/doi.org\/10.1007\/978-981-13-9367-9_10","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"6","key":"1106_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41423-023-00983-5","volume":"20","author":"X Yang","year":"2023","unstructured":"Yang, X., Li, Q., Liu, W., Zong, C., Wei, L., Shi, Y., & Han, Z. (2023). Mesenchymal stromal cells in hepatic fibrosis\/cirrhosis: From pathogenesis to treatment. Cellular & Molecular Immunology, 20(6), 583\u2013599. https:\/\/doi.org\/10.1038\/s41423-023-00983-5","journal-title":"Cellular & Molecular Immunology"},{"issue":"2","key":"1106_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113587","volume":"427","author":"X Yang","year":"2023","unstructured":"Yang, X., Wang, C., Zhu, G., Guo, Z., & Fan, L. (2023). METTL14\/YTHDF1 axis-modified UCHL5 aggravates atherosclerosis by activating the NLRP3 inflammasome. Experimental Cell Research, 427(2), 113587. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113587","journal-title":"Experimental Cell Research"},{"issue":"8","key":"1106_CR10","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1007\/s10238-023-01199-7","volume":"23","author":"S Sun","year":"2023","unstructured":"Sun, S., Shi, D., & Wang, W. (2023). Risk of chronic liver disease and cirrhosis mortality among patients with digestive system cancers: A registry-based analysis. Clinical and Experimental Medicine, 23(8), 5355\u20135365. https:\/\/doi.org\/10.1007\/s10238-023-01199-7","journal-title":"Clinical and Experimental Medicine"},{"key":"1106_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117918","volume":"326","author":"X Yang","year":"2024","unstructured":"Yang, X., Zhang, J., Li, Y., Hu, H., Li, X., Ma, T., & Zhang, B. (2024). Si-Ni-San promotes liver regeneration by maintaining hepatic oxidative equilibrium and glucose\/lipid metabolism homeostasis. Journal of Ethnopharmacology, 326, 117918. https:\/\/doi.org\/10.1016\/j.jep.2024.117918","journal-title":"Journal of Ethnopharmacology"},{"issue":"1","key":"1106_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13020-023-00797-7","volume":"18","author":"Q Shanbo","year":"2023","unstructured":"Shanbo, Q., Peng, T., Junjie, X., Yongfeng, Z., & Junning, Z. (2023). A systematic review of the research progress of traditional Chinese medicine against pulmonary fibrosis: From a pharmacological perspective. Journal of Chinese Medicine, 18(1), 96\u201396.","journal-title":"Journal of Chinese Medicine"},{"key":"1106_CR13","doi-asserted-by":"publisher","DOI":"10.1089\/jmf.2023.K.0273","author":"Q Geng","year":"2024","unstructured":"Geng, Q., Xu, Y., Huang, W., Hu, Y., Jin, H., Hua, H., & Kong, K. (2024). The potential mechanism of the anti-liver fibrotic effect of curcumin in the gut-liver axis. Journal of Medicinal Food. https:\/\/doi.org\/10.1089\/jmf.2023.K.0273","journal-title":"Journal of Medicinal Food"},{"key":"1106_CR14","doi-asserted-by":"publisher","first-page":"123416","DOI":"10.1016\/j.jchromb.2022.123416","volume":"1209","author":"H Bo","year":"2022","unstructured":"Bo, H., Yanping, W., Yujiao, H., Ronghong, L., & Wenjing, L. (2022). Study on the mechanism of anti-hepatic fibrosis of Glycyrrhiza Uralensis\u2013Salvia miltiorrhiza prescription based on serum and urine metabolomics and network pharmacology. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 1209, 123416\u2013123416.","journal-title":"Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences"},{"issue":"3","key":"1106_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.cld.2022.05.001","volume":"26","author":"SA Xanthakos","year":"2022","unstructured":"Xanthakos, S. A. (2022). Nonalcoholic steatohepatitis in children. Clinics in Liver Disease, 26(3), 439\u2013460. https:\/\/doi.org\/10.1016\/j.cld.2022.05.001","journal-title":"Clinics in Liver Disease"},{"issue":"8","key":"1106_CR16","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.stem.2022.07.006","volume":"29","author":"HE Talbott","year":"2022","unstructured":"Talbott, H. E., Mascharak, S., Griffin, M., Wan, D. C., & Longaker, M. T. (2022). Wound healing, fibroblast heterogeneity, and fibrosis. Cell Stem Cell, 29(8), 1161\u20131180. https:\/\/doi.org\/10.1016\/j.stem.2022.07.006","journal-title":"Cell Stem Cell"},{"issue":"4","key":"1106_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/iep.12474","volume":"104","author":"Z Guo","year":"2023","unstructured":"Guo, Z., Liu, X., Zhao, S., Sun, F., Ren, W., & Ma, M. (2023). RUNX1 promotes liver fibrosis progression through regulating TGF-\u03b2 signalling. International Journal of Experimental Pathology, 104(4), 188\u2013198. https:\/\/doi.org\/10.1111\/iep.12474","journal-title":"International Journal of Experimental Pathology"},{"issue":"4","key":"1106_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3325\/cmj.2023.64.243","volume":"64","author":"W Li","year":"2023","unstructured":"Li, W., Jiang, Y., Yu, T. T., Hao, W., & Wang, G. (2023). Lycopene improves autophagy and attenuates carbon tetrachloride-induced hepatic fibrosis in rats. Croatian Medical Journal, 64(4), 243\u2013255. https:\/\/doi.org\/10.3325\/cmj.2023.64.243","journal-title":"Croatian Medical Journal"},{"issue":"2","key":"1106_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.32285","volume":"75","author":"SL Friedman","year":"2022","unstructured":"Friedman, S. L., & Pinzani, M. (2022). Hepatic fibrosis 2022: Unmet needs and a blueprint for the future. Hepatology, 75(2), 473\u2013488. https:\/\/doi.org\/10.1002\/hep.32285","journal-title":"Hepatology"},{"issue":"10","key":"1106_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41575-023-00821-z","volume":"20","author":"B Cogliati","year":"2023","unstructured":"Cogliati, B., Yashaswini, C. N., Wang, S., Sia, D., & Friedman, S. L. (2023). Friend or foe? The elusive role of hepatic stellate cells in liver cancer. Nature Reviews. Gastroenterology & Hepatology, 20(10), 647\u2013661. https:\/\/doi.org\/10.1038\/s41575-023-00821-z","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"4","key":"1106_CR21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.14218\/jcth.2022.00024","volume":"10","author":"B Kaur","year":"2022","unstructured":"Kaur, B., Rosenblatt, R., & Sundaram, V. (2022). Infections in Alcoholic Hepatitis. Journal of Clinical and Translational Hepatology, 10(4), 718\u2013725. https:\/\/doi.org\/10.14218\/jcth.2022.00024","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"Pt A","key":"1106_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109276","volume":"113","author":"J Li","year":"2022","unstructured":"Li, J., Lu, Y., & Lin, G. (2022). Blocking cGAS\/STING signaling protects against sepsis-associated acute liver injury. International Immunopharmacology, 113(Pt A), 109276. https:\/\/doi.org\/10.1016\/j.intimp.2022.109276","journal-title":"International Immunopharmacology"},{"issue":"1","key":"1106_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13020-023-00754-4","volume":"18","author":"DB Ping","year":"2023","unstructured":"Ping, D. B., Sun, X., Peng, Y., & Liu, C. H. (2023). Cyp4a12-mediated retinol metabolism in stellate cells is the antihepatic fibrosis mechanism of the Chinese medicine Fuzheng Huayu recipe. Chinese Medicines, 18(1), 51. https:\/\/doi.org\/10.1186\/s13020-023-00754-4","journal-title":"Chinese Medicines"},{"issue":"8","key":"1106_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"YC Hsu","year":"2023","unstructured":"Hsu, Y. C., Huang, D. Q., & Nguyen, M. H. (2023). Global burden of hepatitis B virus: Current status, missed opportunities and a call for action. Nature Reviews. Gastroenterology & Hepatology, 20(8), 524\u2013537. https:\/\/doi.org\/10.1038\/s41575-023-00760-9","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"9","key":"1106_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s11655-023-3542-2","volume":"29","author":"X Chi","year":"2023","unstructured":"Chi, X., Cheng, D. Y., Sun, X., Liu, S. A., Wang, R. B., Chen, Q., & Xing, H. C. (2023). Efficacy of Biejiajian pill on intestinal microbiota in patients with hepatitis B cirrhosis\/liver fibrosis: A randomized double-blind controlled trial. Chinese Journal of Integrative Medicine, 29(9), 771\u2013781. https:\/\/doi.org\/10.1007\/s11655-023-3542-2","journal-title":"Chinese Journal of Integrative Medicine"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01106-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01106-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01106-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T07:14:00Z","timestamp":1738912440000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01106-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1106"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01106-9","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, there is no professional or other personal interest of any nature or kind in any product, service and\/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled. We confirm that the mentioned received grants in the \u201cAcknowledgement\u201d section, did not lead to any conflicts of interest regarding the publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The manuscript is approved by all authors for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}